The Latest Breaking News from Sackler

OxyContin maker Purdue Pharma's efforts to settle thousands of lawsuits over the toll of opioids is on the verge of approval

Purdue Pharma won court approval to exit bankruptcy, ending six years of litigation over its multibillion-dollar opioid settlement and the Sackler family’s liability releases. Purdue's Chapter 11 plan provides an estimated $7.4 billion to address nationwide opioid harm.

Besides the hefty financial reward, the settlement also ends the Sackler family’s ownership of Purdue Pharma and their ability to sell opioids in the U.S.

The suit, brought by 55 attorneys general, will help compensate victims and fund addiction treatment programmes.

When you think about charitable giving, you probably picture genuine philanthropy and heartfelt generosity. However, the world of charitable tax avoidance reveals a darker side where some wealthy individuals have exploited the system for personal gain. These schemes don’t just bend the rules—they often break them entirely, costing taxpayers billions…

The bland satire in "Death of a Unicorn" makes its message unappetizing; there are tastier options

Sackler family, who owned pharmaceutical company Purdue Pharma, will no longer be in control of the company or permitted to sell opioids if the new settlement plan is approved

New York's AG shared news of The Sackler family and Purdue Pharma settlement, while stating "no amount of money" could reverse the destruction caused.

Members of the Sackler family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion to settle lawsuits over the toll of the powerful prescription painkiller